News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
HanchorBio Receives FDA Orphan Drug Designation for HCB101 in Gastric Cancer
Tuesday, February 17, 2026HanchorBio Inc has received Orphan Drug Designation from the US Food and Drug Administration for HCB to treat gastric cancer The designation applies to gastric cancer broadly including advanced gastric adenocarcinoma in both HERpositive and HERnegati...
EU Parliament Advances Critical Medicines Act to Bolster Europe's Medicine Supply Security in 2026
Tuesday, February 17, 2026The EU Parliament has advanced the Critical Medicines Act aimed at strengthening Europes pharmaceutical supply chain resilience and medicine security starting in
EMA Recommends Withdrawal of Marketing Authorisations for Levamisole Medicines
Monday, February 16, 2026The European Medicines Agency has recommended the withdrawal of marketing authorisations for levamisolecontaining medicines due to safety concerns
Nxera Pharma Announces Operational Highlights and Consolidated Financial Results for Q4 and Full Year 2025
Friday, February 13, 2026Nxera Pharma released its operational highlights and consolidated financial results for the fourth quarter and full year outlining key advancements in its European biopharma pipeline
U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
Thursday, February 12, 2026Novocure has received approval from the US Food and Drug Administration FDA for Optune Pax for the treatment of adults with locally advanced pancreatic cancer The device is approved for use together
EU Pharmacovigilance Regulation Changes Effective February 12, 2026 Impact UK and EU Authorised Medicines
Thursday, February 12, 2026From February amendments to EU Commission Implementing Regulation take effect altering pharmacovigilance requirements for UKauthorised medicines held by companies with dual UKEU licences
Kincell Bio Partners with RegCell to Support Clinical Development of Treg Cell Therapies for Autoimmune Diseases
Wednesday, February 11, 2026Kincell Bio a USbased cell therapy contract development and manufacturing organisation CDMO has announced a collaboration with RegCell a biotechnology company developing an immune tolerance platform
THX Pharma and Biocodex Sign Strategic Licensing Agreement for Rare Disease Drug Candidates
Wednesday, February 11, 2026THX Pharma and Biocodex an independent international pharmaceutical group have entered into a strategic licensing agreement to advance two drug candidates targeting three rare diseases with high unmet medical need
ArisGlobal Launches XDI NavaX Data Intelligence with Three New Agents and NavaX Translation in Madrid
Wednesday, February 11, 2026ArisGlobal a leader in AIdriven Life Sciences technology announced the launch of XDI NavaX Data Intelligence featuring three new agents and NavaX Translation on February in Madrid
Krystal Biotech Secures FDA RMAT Designation for KB707 in Advanced Lung Cancer
Tuesday, February 10, 2026Krystal Biotech has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration for KB its redosable immunotherapy for the treatment of advanced or metastatic nonsmall cell lung cancer NSCLC
